Evidence map›Paper›PMID 41768530›Full record

ArticleNeuroscience applied2026

Sleep, Steps, and Screens: Between- and within-person effects of digital markers of daily life behaviors on smartphone-based assessments of cognitive functioning in depression.

Marcos Ross-Adelman, George Aalbers, Faith Matcham, Daniel Leightley, Carolin Oetzmann, Ewan Carr, Sara Siddi, Josep M Haro, Peter Annas, Maria Dalby and 6 more

Abstract read
In one paragraph

Article in Neuroscience applied, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marcos Ross-AdelmanDepartment of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.
George AalbersDepartment of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.
Faith MatchamDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.
Daniel LeightleySchool of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King's College London, United Kingdom.
Carolin OetzmannDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.
Ewan CarrDepartment of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.
Sara SiddiParc Sanitari Sant Joan de Déu, Sant Joan de Déu Research Institute (IRSJD), CIBERSAM, Barcelona, Spain.
Josep M HaroParc Sanitari Sant Joan de Déu, Sant Joan de Déu Research Institute (IRSJD), CIBERSAM, Barcelona, Spain.
Peter AnnasH. Lundbeck A/S, Valby, Denmark.
Maria DalbyMuna Therapeutics, Copenhagen, Denmark.
Vaibhav A NarayanDavos Alzheimer's Collaborative (DAC), Geneva, Switzerland.
Matthew HotopfDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.
Inez Myin-GermeysDepartment of Neurosciences, Center of Contextual Psychiatry, KU Leuven, Belgium.
Femke LamersDepartment of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.
Brenda W J H PenninxDepartment of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.
RADAR-CNS consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive impairment represents a core feature of major depressive disorder (MDD), often persisting after mood symptoms remit and not addressed by usual antidepressant treatments. Despite its relevance, cognition is typically assessed with infrequent tests in clinical settings, overlooking its contextual nature. Smartphones and wearables enable ecologically valid, repeated measurements of cognition and daily life behaviors that may impact it. We examined whether sleep duration, step count, and smartphone screen time are associated with cognitive functioning in MDD. We conducted secondary analyses of RADAR-MDD, a multicenter study following individuals with recurrent MDD. Cognitive functioning - self-reported and performance-based - was assessed with the THINC-it® app. Sleep duration and step count were measured with Fitbit devices, and screen time with the RADAR-Base app. Cognitive assessments (outcomes) were linked to behavioral measures (predictors) from the day of and the day preceding each assessment. Two-level multilevel models estimated between-person (differences in participant means) and within-person (deviations from participant means) effects. The sample included 502 participants, further subdivided by behavior-cognitive outcome pair. For performance-based cognitive assessments, positive associations at the between-person level were found for step count (β = 0.104, SE = 0.031, p < 0.001) and screen time (β = 0.075, SE = 0.036, p = 0.038), and sleep duration showed a quadratic negative effect (β = -0.080, SE = 0.018, p < 0.001). No within-person effects were detected. For self-reported cognitive functioning, step count showed positive associations both between (β = 0.161, SE = 0.037, p < 0.001) and within persons (β = 0.027, SE = 0.010, p = 0.005), while screen time was negatively associated within persons (β = -0.033, SE = 0.011, p = 0.002). Our findings illustrate that smartphones and wearables can collect meaningful daily life data of MDD patients that can be used to support cognitive health. Step count emerges as a promising behavioral target as it is simple to track and is correlated with better cognitive outcomes.

Indexed as

Ambulatory assessmentCognitive functioningDigital healthMajor depressive disorderPatient monitoring

Identifiers

PMID41768530
PMCPMC12936773

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.